Analysts expect Adaptimmune Therapeutics PLC to report revenue of 4.69 M for Q3 25, against a range of 4.31 M to 5.07 M. The most recent reported quarter, Q2 25, came in at 13.68 M, a 50.7% beat against the 9.08 M consensus.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 128.23 M | 40.90 M | 3.20 M | 7.29 M | 13.68 M | - | - | - | - | - | - | - | - | ||||||||||||||
| High Estimate | 42.24 M | 19.24 M | 8.01 M | 7.49 M | 9.50 M | 5.07 M | 4.95 M | 0.00 | 0.00 | 0.00 | 0.00 | 36.60 M | 31.49 M | ||||||||||||||
| Low Estimate | 36.59 M | 16.77 M | 7.35 M | 6.21 M | 8.65 M | 4.31 M | 4.24 M | 0.00 | 0.00 | 0.00 | 0.00 | 33.60 M | 28.57 M | ||||||||||||||
| Consensus Estimate | 39.42 M | 18.01 M | 7.68 M | 6.85 M | 9.08 M | 4.69 M | 4.59 M | 0.00 | 0.00 | 0.00 | 0.00 | 35.10 M | 30.03 M |
Analysts expect Adaptimmune Therapeutics PLC to report earnings per share of -0.11 for Q3 25, against a range of -0.12 to -0.10. The most recent reported quarter, Q2 25, came in at -0.02, a 50.0% beat against the -0.04 consensus.
| Metric | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 0.04 | -0.01 | -0.05 | -0.03 | -0.02 | - | - | - | - | - | - | - | - | ||||||||||||||
| High Estimate | -0.04 | -0.01 | -0.03 | -0.08 | -0.04 | -0.10 | -0.05 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | ||||||||||||||
| Low Estimate | -0.04 | -0.01 | -0.03 | -0.10 | -0.04 | -0.12 | -0.07 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | ||||||||||||||
| Consensus Estimate | -0.04 | -0.01 | -0.03 | -0.09 | -0.04 | -0.11 | -0.06 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 |
Pull Wall Street consensus for Adaptimmune Therapeutics PLC (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=ADAPY&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "ADAPY", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=ADAPY&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();